2nd Quarter - Report
ACG ADVOCACY for GENENTECH INC
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Cyber Security H.R.942 - American Research and Competitiveness Act of 2011 S. 23: America Invents Act H.R. 1249: Leahy-Smith America Invents Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRIS ISRAEL | — |
| IAN P MUSSELMAN | — |
| DAVID J URBAN | — |
Health Issues HCR
Prescription Drug User Fee Act (PDUFA) Reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRIS ISRAEL | Dept Asst Sec for Tech Policy, Dept of Commerce |
| IAN P MUSSELMAN | — |
| DAVID J URBAN | Chief of Staff, Senator Arlen Specter |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| F. HOFFMANN-LA ROCHE LTD. | Switzerland | Switzerland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.